This article corrects:
Comparison of Efficacy of Long‐term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease (pages 1479–1487).
U. Sent, R. Gössl, J. Elliott, H. M. Syme and T. Zimmering
Article first published online: 16 OCT 2015 | DOI: 10.1111/jvim.13639
In Table 2 the number 7 is missing in the Telmisartan group, IRIS 2b, substagin UP/C >0.4.
Table 1.
Telmisartan and Benazepril group (intention‐to‐treat population, n = 112 each), IRIS stage at baseline including substaging
| Telmisartan (n = 112)a | IRIS Stage 2a (n = 36) | IRIS Stage 2b (n = 48) | IRIS Stage 3 (n = 21) | IRIS Stage 4 (n = 3)b |
|---|---|---|---|---|
| Substaging by SBP | ||||
| <150 mmHg | 17 | 30 | 6 | 1 |
| 150–159 mmHg | 11 | 5 | 5 | 1 |
| 160–179 mmHg | 8 | 13 | 10 | 0 |
| ≥180 mmHg | 0 | 0 | 0 | 0 |
| Substaging by UP/Ca | ||||
| <0.2 | 1 | 1 | 0 | 0 |
| 0.2–1.4 | 26 | 40 | 13 | 0 |
| >0.4 | 9 | 7 | 8 | 2 |
| Benazepril (n = 112) | IRIS Stage 2a (n = 47) | IRIS Stage 2b (n = 44) | IRIS Stage 3 (n = 19) | IRIS Stage 4(n = 2) |
|---|---|---|---|---|
| Substaging by SBP | ||||
| <150 mmHg | 24 | 18 | 8 | 1 |
| 150–159 mmHg | 7 | 9 | 5 | 1 |
| 160–179 mmHg | 16 | 16 | 6 | o |
| ≥180 mmHg | 0 | 1 | 0 | 0 |
| Substaging by UP/C | ||||
| <0.2 | 0 | 1 | 0 | 0 |
| 0.2–0.4 | 42 | 31 | 15 | 1 |
| >0.4 | 5 | 12 | 4 | 1 |
a
IRIS stage 1 (n = 4) not shown.
b
One missing value for IRIS 4.